Nuveen LLC Buys Shares of 361,970 Ryan Specialty Holdings Inc. $RYAN

Nuveen LLC purchased a new position in shares of Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 361,970 shares of the company's stock, valued at approximately $26,739,000. Nuveen LLC owned about 0.14% of Ryan Specialty as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. GAMMA Investing LLC increased its position in shares of Ryan Specialty by 21.8% during the 1st quarter. GAMMA Investing LLC now owns 2,101 shares of the company's stock worth $155,000 after purchasing an additional 376 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its position in shares of Ryan Specialty by 3.9% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 12,215 shares of the company's stock worth $902,000 after purchasing an additional 460 shares during the last quarter. Wealth Alliance LLC acquired a new position in shares of Ryan Specialty during the 1st quarter worth approximately $303,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Ryan Specialty during the 1st quarter worth approximately $1,927,000. Finally, Sumitomo Life Insurance Co. acquired a new position in shares of Ryan Specialty during the 1st quarter worth approximately $1,056,000. Institutional investors and hedge funds own 84.82% of the company's stock.

Ryan Specialty Stock Performance

NYSE RYAN traded up $0.2130 on Thursday, reaching $59.9730. The stock had a trading volume of 620,237 shares, compared to its average volume of 1,076,131. The company has a debt-to-equity ratio of 2.88, a current ratio of 1.01 and a quick ratio of 1.01. The firm has a fifty day moving average of $63.87 and a two-hundred day moving average of $67.58. Ryan Specialty Holdings Inc. has a 1-year low of $55.77 and a 1-year high of $77.16. The company has a market cap of $15.81 billion, a P/E ratio of 171.54, a price-to-earnings-growth ratio of 1.64 and a beta of 0.64.

Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The company reported $0.66 EPS for the quarter, meeting analysts' consensus estimates of $0.66. Ryan Specialty had a return on equity of 48.70% and a net margin of 6.81%.The firm had revenue of $855.17 million for the quarter, compared to analyst estimates of $837.52 million. During the same period in the prior year, the firm posted $0.58 EPS. The company's revenue for the quarter was up 23.0% on a year-over-year basis. On average, equities research analysts anticipate that Ryan Specialty Holdings Inc. will post 2.29 EPS for the current year.

Ryan Specialty Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, August 26th. Stockholders of record on Tuesday, August 12th will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Tuesday, August 12th. Ryan Specialty's dividend payout ratio is presently 137.14%.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the company. Citigroup assumed coverage on Ryan Specialty in a research report on Wednesday, August 13th. They set a "buy" rating and a $74.00 price target on the stock. Wall Street Zen raised Ryan Specialty from a "sell" rating to a "hold" rating in a report on Sunday, August 3rd. Morgan Stanley decreased their target price on Ryan Specialty from $71.00 to $68.00 and set an "overweight" rating on the stock in a report on Monday. Cantor Fitzgerald raised Ryan Specialty to a "hold" rating in a report on Wednesday, August 13th. Finally, The Goldman Sachs Group raised Ryan Specialty from a "neutral" rating to a "buy" rating and boosted their target price for the stock from $74.00 to $81.00 in a report on Tuesday, May 13th. Nine investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, Ryan Specialty presently has a consensus rating of "Moderate Buy" and a consensus target price of $74.83.

Insiders Place Their Bets

In other news, Director David P. Bolger sold 5,000 shares of the company's stock in a transaction on Tuesday, June 3rd. The stock was sold at an average price of $70.80, for a total transaction of $354,000.00. Following the completion of the sale, the director directly owned 71,467 shares in the company, valued at approximately $5,059,863.60. This represents a 6.54% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Mark Stephen Katz sold 14,377 shares of the company's stock in a transaction on Friday, June 13th. The shares were sold at an average price of $65.84, for a total value of $946,581.68. Following the sale, the executive vice president owned 1,117 shares of the company's stock, valued at approximately $73,543.28. The trade was a 92.79% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 52.21% of the company's stock.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.